logo

Sign me up!

FREE MEMBERSHIP

Get your FREE Innovation in Textiles membership. Sign up now...

Technical Absorbents
Technical Absorbents

1st July 2020, Houston, TX

FDA approval sought for SARS-CoV-2 deactivating Acteev technology

© Ascend Performance Materials.

© Ascend Performance Materials.

Ascend Performance Materials has announced it has submitted its first FDA 510(k) for clearance to market its patent pending Acteev technology in the United States in a medical device, a surgical mask under a new brand called Acteev Biodefend. Independent laboratory testing has found Acteev materials to achieve greater than 99% efficacy at deactivating bacteria, fungi and viruses, including SARS-CoV-2, the company reports.

“We’ve partnered with independent labs for comprehensive testing and have reallocated resources to ready ourselves for world-scale production upon receiving regulatory clearance,” said Vikram Gopal, Ph.D., Ascend’s chief technology officer.

Acteev Biodefend technology has been shown in laboratory tests to deactivate SARS-CoV-2, the coronavirus that causes COVID-19, and other pathogens including H1N1, coronavirus 229E and Gram-positive and Gram-negative bacteria such as staphylococcus and E. coli, Dr. Gopal said. The testing was conducted following the protocols of ISO, ASTM and other international standards organizations.

Acteev technology, covered by more than 15 patent families, embeds active zinc ions into the matrix of a specialty polymer. “What is unique about Acteev is the marriage between the antimicrobial ingredient like zinc and the specialty polymer that keeps the zinc ions active and bound at all times,” Dr. Gopal said.

“Because it isn’t a simple topical finish or coating, the antimicrobial protection can last much longer – it will not flake off or be worn away. And, unlike some other antimicrobials, zinc is environmentally friendly.”

Acteev technology has been tested in multiple end forms, including knit and woven fabrics; engineered plastics; and nanofiber, meltblown and spunbond nonwoven materials. Acteev Biodefend could provide an answer to the calls to identify an immediate, positive solution to restart the economy and reopen our schools and universities safely, Dr. Gopal said.

“The current global scarcity of pathogen-resistant materials is not going to end unless scientists and engineers look for novel ways to face the challenge, and we are proud to submit Acteev Biodefend as a potential solution,” Dr. Gopal said.

 Earlier this month, Ascend launched Acteev Protect, an antimicrobial line of protection specially formulated to guard against the growth of fungi, bacteria and other microbes to keep textiles and nonwoven fabrics fresher for longer. Acteev Protect, available for sale today in the United States and select other jurisdictions, can be used to make face coverings, filtration devices, and textiles for upholstery and apparel such as activewear.

www.ascendmaterials.com

This article is also appears in...

Comments

Be the first to comment on FDA approval sought for SARS-CoV-2 deactivating Acteev technology

|